282 related articles for article (PubMed ID: 19926892)
1. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.
Menke J; Rabacal WA; Byrne KT; Iwata Y; Schwartz MM; Stanley ER; Schwarting A; Kelley VR
J Am Soc Nephrol; 2009 Dec; 20(12):2581-92. PubMed ID: 19926892
[TBL] [Abstract][Full Text] [Related]
2. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
Lenda DM; Stanley ER; Kelley VR
J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
[TBL] [Abstract][Full Text] [Related]
3. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
[TBL] [Abstract][Full Text] [Related]
4. Aberrant macrophages mediate defective kidney repair that triggers nephritis in lupus-susceptible mice.
Iwata Y; Boström EA; Menke J; Rabacal WA; Morel L; Wada T; Kelley VR
J Immunol; 2012 May; 188(9):4568-80. PubMed ID: 22467656
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of CSF-1 isoforms in lupus nephritis.
Menke J; Iwata Y; Rabacal WA; Basu R; Stanley ER; Kelley VR
J Am Soc Nephrol; 2011 Oct; 22(10):1821-33. PubMed ID: 21885670
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
[TBL] [Abstract][Full Text] [Related]
7. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice.
Schwarting A; Wada T; Kinoshita K; Tesch G; Kelley VR
J Immunol; 1998 Jul; 161(1):494-503. PubMed ID: 9647261
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
Moore KJ; Yeh K; Naito T; Kelley VR
J Immunol; 1996 Jul; 157(1):427-32. PubMed ID: 8683148
[TBL] [Abstract][Full Text] [Related]
10. Enhanced response of macrophages to CSF-1 in autoimmune mice: a gene transfer strategy.
Moore KJ; Naito T; Martin C; Kelley VR
J Immunol; 1996 Jul; 157(1):433-40. PubMed ID: 8683149
[TBL] [Abstract][Full Text] [Related]
11. Pivotal role of colony stimulating factor-1 in lupus nephritis.
Rubin Kelley V; Bloom RD; Yui MA; Martin C; Price D
Kidney Int Suppl; 1994 Feb; 45():S83-5. PubMed ID: 8158905
[TBL] [Abstract][Full Text] [Related]
12. Nephritogenic cytokines and disease in MRL-Fas(lpr) kidneys are dependent on multiple T-cell subsets.
Wada T; Schwarting A; Chesnutt MS; Wofsy D; Rubin Kelley V
Kidney Int; 2001 Feb; 59(2):565-78. PubMed ID: 11168938
[TBL] [Abstract][Full Text] [Related]
13. Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice.
Menke J; Hsu MY; Byrne KT; Lucas JA; Rabacal WA; Croker BP; Zong XH; Stanley ER; Kelley VR
J Immunol; 2008 Nov; 181(10):7367-79. PubMed ID: 18981160
[TBL] [Abstract][Full Text] [Related]
14. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice.
Yui MA; Brissette WH; Brennan DC; Wuthrich RP; Rubin-Kelley VE
Am J Pathol; 1991 Aug; 139(2):255-61. PubMed ID: 1867317
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
Hu L; Hu J; Chen L; Zhang Y; Wang Q; Yang X
Front Immunol; 2021; 12():584414. PubMed ID: 33717066
[TBL] [Abstract][Full Text] [Related]
16. Colony-stimulating factor-1: a potential biomarker for lupus nephritis.
Menke J; Amann K; Cavagna L; Blettner M; Weinmann A; Schwarting A; Kelley VR
J Am Soc Nephrol; 2015 Feb; 26(2):379-89. PubMed ID: 25012167
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
18. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
[TBL] [Abstract][Full Text] [Related]
19. Colony stimulating factor-1 in the induction of lupus nephritis.
Bloom RD; Florquin S; Singer GG; Brennan DC; Kelley VR
Kidney Int; 1993 May; 43(5):1000-9. PubMed ID: 8510378
[TBL] [Abstract][Full Text] [Related]
20. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
Chalmers SA; Wen J; Shum J; Doerner J; Herlitz L; Putterman C
Clin Immunol; 2017 Dec; 185():100-108. PubMed ID: 27570219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
